Selected article for: "cancer development and nervous system"
Author: Oliveros-Díaz, Andrés; Olivero-Verbel, Jesús; Pájaro-González, Yina; Díaz-Castillo, Fredyc
Title: Molecular Human Targets of Bioactive Alkaloid-Type Compounds from Tabernaemontana cymose Jacq.
  • Cord-id: tqfiiac7
  • Document date: 2021_6_21
    • ID: tqfiiac7
    Snippet: Alkaloids are a group of secondary metabolites that have been widely studied for the discovery of new drugs due to their properties on the central nervous system and their anti-inflammatory, antioxidant and anti-cancer activities. Molecular docking was performed for 10 indole alkaloids identified in the ethanol extract of Tabernaemontana cymosa Jacq. with 951 human targets involved in different diseases. The results were analyzed through the KEGG and STRING databases, finding the most relevant p
    Document: Alkaloids are a group of secondary metabolites that have been widely studied for the discovery of new drugs due to their properties on the central nervous system and their anti-inflammatory, antioxidant and anti-cancer activities. Molecular docking was performed for 10 indole alkaloids identified in the ethanol extract of Tabernaemontana cymosa Jacq. with 951 human targets involved in different diseases. The results were analyzed through the KEGG and STRING databases, finding the most relevant physiological associations for alkaloids. The molecule 5-oxocoronaridine proved to be the most active molecule against human proteins (binding energy affinity average = −9.2 kcal/mol) and the analysis of the interactions between the affected proteins pointed to the PI3K/ Akt/mTOR signaling pathway as the main target. The above indicates that indole alkaloids from T. cymosa constitute a promising source for the search and development of new treatments against different types of cancer.

    Search related documents:
    Co phrase search for related documents
    • activation inhibition and low activity: 1, 2
    • activation inhibition and lung cancer: 1, 2, 3, 4
    • activation inhibition and lung cancer cell: 1, 2, 3
    • activation inhibition and lung disease: 1, 2, 3, 4
    • activity broad spectrum and long pandemic: 1
    • activity broad spectrum and low activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • activity broad spectrum and lung cancer: 1
    • activity broad spectrum and lung cancer cell: 1
    • activity broad spectrum and lung disease: 1, 2
    • activity variation and low activity: 1, 2, 3, 4